Scotiabank raised the firm’s price target on Nutrien (NTR) to $60 from $59 and keeps an Outperform rating on the shares. In the near term, the firm sees no reason why Nutrien’s share price won’t continue to benefit from the rally in nitrogen and potassium, the analyst tells investors. Beyond the spring, however, the stock is at risk of stalling, the firm adds. While Scotiabank sees long-term value in the company, the firm continues to inch closer to a Hold rating.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.